EW News and Press, Edwards Lifesciences Corporation From 05/01/19

Introduction Edwards Lifesciences ( EW ) is a leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. The company is also an established player hemodynamic monitoring systems in the hospital setting. In the ...

IRVINE, Calif. , May 1, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will host its Annual Meeting of Stockholders on Wednesday, May 8, 2019 beginning at 10:0...

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Today's Top Stories: Microsoft, Tesla in full earnings slate; Treasury yields lower after stronger earnings; and report: CBS CEO search complicated by concerns of looming merger. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the followin...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). U.S. futures were down slightly early Wednesday ahead of another full day of earnings. Pre-market repor...

Edwards Lifesciences Corporation (EW) Q1 2019 Earnings Conference Call April 23, 2019, 5:00 pm ET Company Participants Mike Mussallem - Chairman & CEO Scott Ullem - CFO Conference Call Participants Vijay Kumar - Evercore ISI David Lewis - Morgan Stanley Bob Hopkins - ...

Edwards Lifesciences (NYSE: EW ) Q1 results ($M): Sales: 993.0 (+11.0%); TAVR: 597.7 (+8.5%); Surgical Structural Heart: 214.7 (+19.6%); Critical Care: 176.3 (+7.7%). More news on: Edwards Lifesciences Corporation, Healthcare stocks news, Earnings news and commentary, Read more ...

Edwards Lifesciences (NYSE: EW ): Q1 Non-GAAP EPS of $1.32 beats by $0.10 ; GAAP EPS of $1.18. More news on: Edwards Lifesciences Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...

IRVINE, Calif. , April 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2019. ...